More black men to benefit from prostate cancer screening trial

• Black men are being actively recruited to prostate cancer screening trials, addressing previous underrepresentation in research and ensuring findings are applicable to this higher-risk population
• Current PSA blood testing alone is insufficient for prostate cancer screening, highlighting the need for improved diagnostic approaches being evaluated in clinical trials
• Trial findings will help establish evidence-based screening protocols tailored to different risk groups, potentially improving early detection outcomes

Experts are trying to find the best way to screen for prostate cancer, since blood tests alone are not accurate enough for most men.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.